Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
Identifieur interne : 004904 ( Main/Exploration ); précédent : 004903; suivant : 004905Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
Auteurs : Martin J. Vincent [États-Unis] ; Eric Bergeron ; Suzanne Benjannet ; Bobbie R. Erickson ; Pierre E. Rollin ; Thomas G. Ksiazek ; Nabil G. Seidah ; Stuart T. NicholSource :
- Virology journal [ 1743-422X ] ; 2005.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (pharmacologie), Cellules Vero, Chloroquine (pharmacologie), Chlorure d'ammonium (pharmacologie), Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (métabolisme), Glycosylation, Peptidyl-Dipeptidase A (métabolisme), Protéines de l'enveloppe virale (métabolisme), Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (métabolisme), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (virologie), Technique d'immunofluorescence indirecte, Virus du SRAS ().
- MESH :
- métabolisme : Glycoprotéines membranaires, Peptidyl-Dipeptidase A, Protéines de l'enveloppe virale, Syndrome respiratoire aigu sévère.
- pharmacologie : Antiviraux, Chloroquine, Chlorure d'ammonium.
- traitement médicamenteux : Syndrome respiratoire aigu sévère.
- virologie : Syndrome respiratoire aigu sévère.
- Animaux, Cellules Vero, Glycoprotéine de spicule des coronavirus, Glycosylation, Syndrome respiratoire aigu sévère, Technique d'immunofluorescence indirecte, Virus du SRAS.
English descriptors
- KwdEn :
- Ammonium Chloride (pharmacology), Animals, Antiviral Agents (pharmacology), Chlorocebus aethiops, Chloroquine (pharmacology), Fluorescent Antibody Technique, Indirect, Glycosylation, Membrane Glycoproteins (metabolism), Peptidyl-Dipeptidase A (metabolism), SARS Virus (drug effects), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (metabolism), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (virology), Spike Glycoprotein, Coronavirus, Vero Cells, Viral Envelope Proteins (metabolism).
- MESH :
- chemical , metabolism : Membrane Glycoproteins, Peptidyl-Dipeptidase A, Viral Envelope Proteins.
- chemical , pharmacology : Ammonium Chloride, Antiviral Agents, Chloroquine.
- drug effects : SARS Virus.
- drug therapy : Severe Acute Respiratory Syndrome.
- metabolism : Severe Acute Respiratory Syndrome.
- prevention & control : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Chlorocebus aethiops, Fluorescent Antibody Technique, Indirect, Glycosylation, Spike Glycoprotein, Coronavirus, Vero Cells.
Abstract
Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.
DOI: 10.1186/1743-422X-2-69
PubMed: 16115318
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002576
- to stream PubMed, to step Curation: 002576
- to stream PubMed, to step Checkpoint: 002797
- to stream Ncbi, to step Merge: 001126
- to stream Ncbi, to step Curation: 001126
- to stream Ncbi, to step Checkpoint: 001126
- to stream Main, to step Merge: 004C20
- to stream Main, to step Curation: 004904
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.</title><author><name sortKey="Vincent, Martin J" sort="Vincent, Martin J" uniqKey="Vincent M" first="Martin J" last="Vincent">Martin J. Vincent</name><affiliation wicri:level="1"><nlm:affiliation>Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. mvincent@cdc.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333</wicri:regionArea><wicri:noRegion>Georgia 30333</wicri:noRegion></affiliation></author><author><name sortKey="Bergeron, Eric" sort="Bergeron, Eric" uniqKey="Bergeron E" first="Eric" last="Bergeron">Eric Bergeron</name></author><author><name sortKey="Benjannet, Suzanne" sort="Benjannet, Suzanne" uniqKey="Benjannet S" first="Suzanne" last="Benjannet">Suzanne Benjannet</name></author><author><name sortKey="Erickson, Bobbie R" sort="Erickson, Bobbie R" uniqKey="Erickson B" first="Bobbie R" last="Erickson">Bobbie R. Erickson</name></author><author><name sortKey="Rollin, Pierre E" sort="Rollin, Pierre E" uniqKey="Rollin P" first="Pierre E" last="Rollin">Pierre E. Rollin</name></author><author><name sortKey="Ksiazek, Thomas G" sort="Ksiazek, Thomas G" uniqKey="Ksiazek T" first="Thomas G" last="Ksiazek">Thomas G. Ksiazek</name></author><author><name sortKey="Seidah, Nabil G" sort="Seidah, Nabil G" uniqKey="Seidah N" first="Nabil G" last="Seidah">Nabil G. Seidah</name></author><author><name sortKey="Nichol, Stuart T" sort="Nichol, Stuart T" uniqKey="Nichol S" first="Stuart T" last="Nichol">Stuart T. Nichol</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16115318</idno><idno type="pmid">16115318</idno><idno type="doi">10.1186/1743-422X-2-69</idno><idno type="wicri:Area/PubMed/Corpus">002576</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002576</idno><idno type="wicri:Area/PubMed/Curation">002576</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002576</idno><idno type="wicri:Area/PubMed/Checkpoint">002797</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002797</idno><idno type="wicri:Area/Ncbi/Merge">001126</idno><idno type="wicri:Area/Ncbi/Curation">001126</idno><idno type="wicri:Area/Ncbi/Checkpoint">001126</idno><idno type="wicri:Area/Main/Merge">004C20</idno><idno type="wicri:Area/Main/Curation">004904</idno><idno type="wicri:Area/Main/Exploration">004904</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.</title><author><name sortKey="Vincent, Martin J" sort="Vincent, Martin J" uniqKey="Vincent M" first="Martin J" last="Vincent">Martin J. Vincent</name><affiliation wicri:level="1"><nlm:affiliation>Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. mvincent@cdc.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333</wicri:regionArea><wicri:noRegion>Georgia 30333</wicri:noRegion></affiliation></author><author><name sortKey="Bergeron, Eric" sort="Bergeron, Eric" uniqKey="Bergeron E" first="Eric" last="Bergeron">Eric Bergeron</name></author><author><name sortKey="Benjannet, Suzanne" sort="Benjannet, Suzanne" uniqKey="Benjannet S" first="Suzanne" last="Benjannet">Suzanne Benjannet</name></author><author><name sortKey="Erickson, Bobbie R" sort="Erickson, Bobbie R" uniqKey="Erickson B" first="Bobbie R" last="Erickson">Bobbie R. Erickson</name></author><author><name sortKey="Rollin, Pierre E" sort="Rollin, Pierre E" uniqKey="Rollin P" first="Pierre E" last="Rollin">Pierre E. Rollin</name></author><author><name sortKey="Ksiazek, Thomas G" sort="Ksiazek, Thomas G" uniqKey="Ksiazek T" first="Thomas G" last="Ksiazek">Thomas G. Ksiazek</name></author><author><name sortKey="Seidah, Nabil G" sort="Seidah, Nabil G" uniqKey="Seidah N" first="Nabil G" last="Seidah">Nabil G. Seidah</name></author><author><name sortKey="Nichol, Stuart T" sort="Nichol, Stuart T" uniqKey="Nichol S" first="Stuart T" last="Nichol">Stuart T. Nichol</name></author></analytic><series><title level="j">Virology journal</title><idno type="eISSN">1743-422X</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ammonium Chloride (pharmacology)</term><term>Animals</term><term>Antiviral Agents (pharmacology)</term><term>Chlorocebus aethiops</term><term>Chloroquine (pharmacology)</term><term>Fluorescent Antibody Technique, Indirect</term><term>Glycosylation</term><term>Membrane Glycoproteins (metabolism)</term><term>Peptidyl-Dipeptidase A (metabolism)</term><term>SARS Virus (drug effects)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (metabolism)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Spike Glycoprotein, Coronavirus</term><term>Vero Cells</term><term>Viral Envelope Proteins (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (pharmacologie)</term><term>Cellules Vero</term><term>Chloroquine (pharmacologie)</term><term>Chlorure d'ammonium (pharmacologie)</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires (métabolisme)</term><term>Glycosylation</term><term>Peptidyl-Dipeptidase A (métabolisme)</term><term>Protéines de l'enveloppe virale (métabolisme)</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (métabolisme)</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Technique d'immunofluorescence indirecte</term><term>Virus du SRAS ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Membrane Glycoproteins</term><term>Peptidyl-Dipeptidase A</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Ammonium Chloride</term><term>Antiviral Agents</term><term>Chloroquine</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycoprotéines membranaires</term><term>Peptidyl-Dipeptidase A</term><term>Protéines de l'enveloppe virale</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term><term>Chloroquine</term><term>Chlorure d'ammonium</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Chlorocebus aethiops</term><term>Fluorescent Antibody Technique, Indirect</term><term>Glycosylation</term><term>Spike Glycoprotein, Coronavirus</term><term>Vero Cells</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Cellules Vero</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycosylation</term><term>Syndrome respiratoire aigu sévère</term><term>Technique d'immunofluorescence indirecte</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Benjannet, Suzanne" sort="Benjannet, Suzanne" uniqKey="Benjannet S" first="Suzanne" last="Benjannet">Suzanne Benjannet</name><name sortKey="Bergeron, Eric" sort="Bergeron, Eric" uniqKey="Bergeron E" first="Eric" last="Bergeron">Eric Bergeron</name><name sortKey="Erickson, Bobbie R" sort="Erickson, Bobbie R" uniqKey="Erickson B" first="Bobbie R" last="Erickson">Bobbie R. Erickson</name><name sortKey="Ksiazek, Thomas G" sort="Ksiazek, Thomas G" uniqKey="Ksiazek T" first="Thomas G" last="Ksiazek">Thomas G. Ksiazek</name><name sortKey="Nichol, Stuart T" sort="Nichol, Stuart T" uniqKey="Nichol S" first="Stuart T" last="Nichol">Stuart T. Nichol</name><name sortKey="Rollin, Pierre E" sort="Rollin, Pierre E" uniqKey="Rollin P" first="Pierre E" last="Rollin">Pierre E. Rollin</name><name sortKey="Seidah, Nabil G" sort="Seidah, Nabil G" uniqKey="Seidah N" first="Nabil G" last="Seidah">Nabil G. Seidah</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Vincent, Martin J" sort="Vincent, Martin J" uniqKey="Vincent M" first="Martin J" last="Vincent">Martin J. Vincent</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004904 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004904 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:16115318
|texte= Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16115318" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |